Zack Z. Ramilevich, M.D., Joins Marcus Neuroscience Institute as a General Neurologist - Summary - MDSpire

Zack Z. Ramilevich, M.D., Joins Marcus Neuroscience Institute as a General Neurologist

Board-certified neurologist Zack Z. Ramilevich, M.D., has joined Marcus Neuroscience Institute, part of Baptist Health, as a general neurologist.

  • By

  • March 26, 2026

  • 2 min

Share

Objective:

To introduce Dr. Zack Z. Ramilevich as a new general neurologist at Marcus Neuroscience Institute, highlighting his role in enhancing patient care.

Key Findings:
  • Dr. Ramilevich is board-certified and has experience with a wide range of neurological conditions, including headache disorders, dementia, stroke, neuropathy, Parkinson’s disease, autoimmune neurological conditions, and adult epilepsy.
  • He has a commitment to holistic, patient-centered neurological care.
  • His training includes significant contributions to clinical research and educational lectures on various neurological topics.
Interpretation:

Dr. Ramilevich's addition to the team enhances the quality of neurological care available at the institute, significantly benefiting both patients and the broader community.

Limitations:
Conclusion:

Dr. Ramilevich's expertise in general neurology, dedication to patient care, and contributions to research will be a valuable asset to Marcus Neuroscience Institute.

Original Source(s)

Zack Z. Ramilevich, M.D., Joins Marcus Neuroscience Institute as a General Neurologist

  • by

  • March 26, 2026

Related Content

Advancing Alzheimer Disease Prediction With Large Language Model–Based Linguistic Feature Analysis: Development and Validation Study

Carotid Endarterectomy: Surgical Treatment for Symptomatic Carotid Artery Disease

In this procedural case review, vascular surgeon Dr. Samuel Steerman performs a right carotid endarterectomy on a woman in her 60s who experienced a stroke related to carotid artery plaque.

  • May 27, 2026

  • 1 min
The effects of transcranial direct current stimulation on global cognitive function, visuospatial function, and executive function in patients with mild cognitive impairment and Alzheimer’s disease: a meta-analysis